Palantir is turning the NHS into a tool for mass surveillance

Spread the love

Article by Jade-Ruyu Yan and Aman Sethi republished from openDemocracy under a Creative Commons Attribution-NonCommercial 4.0 International licence.

Composition by James Battershill

Kicking out Palantir, experts warn, may not solve the problems its Federated Data Platform has created.

NHS England’s Federated Data Platform, run primarily by controversial US military contractor Palantir, would give a future UK government the ability to use patients’ healthcare data to unleash unprecedented mass surveillance, experts and technologists have warned openDemocracy.

“We have already seen in the US how Palantir’s reach into so many different areas of government has allowed it to build a system that provides detailed profiles of people to enable ICE raids,” said Duncan McCann of the Good Law Project, referring to how President Donald Trump’s mass deportation programme has used Palantir’s tools. “The exact same thing is being enabled by the integration of Palantir into the UK public sector.”

This risk is only exacerbated by the fact that nearly three years after Palantir was awarded the £330m contract to run the FDP, it remains unclear what patient data it gathers, on what basis and to what end. Despite this, 69% of regional NHS Trusts have already adopted the platform, which provides the health service with a new operating system intended to link up otherwise unconnected databases and disparate software across different NHS services and regions.

This lack of clarity was laid bare this week, when the UK’s cross-party Science, Innovation and Technology Committee urged the government to break the NHS’s contract with Palantir. Its report contained a stark recommendation to the government: reveal “the exact nature of Palantir’s access to identifiable and non-identifiable patient data, on what statutory basis this was authorised, when, and by whom.”

McCann and the Good Law Project are part of an unusually wide coalition demanding the UK cut ties with Palantir, but technologists who have worked closely on the FDP warn that the genie is now out of the bottle; kicking the US giant out of the NHS may not be enough to solve the data privacy problems its Federated Data Platform has created.

“You know you could pull Palantir out,” Tom Bartlett, an NHS technologist who worked on the FDP and has spoken publicly in favour of the project, told openDemocracy. “But the danger remains.”

“You still might get a government that says, ‘We need to have the data from the NHS and the data from the Home Office connected, and we want to use it for the purpose of denying people healthcare or deporting people or whatever’.”

Coalition of Resistance

To understand how deeply Palantir is enmeshed in the UK’s public sector, consider the coalition opposed to it.

NHS data analysts and chief data and analytical officers have spoken out against the FDP. The British Medical Association, a union representing doctors and medical students, has urged GPs to reject it. The Greater Manchester Integrated Care Board, which oversees NHS services for 2.8 million people, has refused to sign up to the platform, claiming outstanding security risks haven’t been addressed, and that it has better technology in-house.

It’s not just the NHS, either. London’s mayor has blocked a £50m Palantir contract with the Metropolitan Police, arguing that it was improperly awarded. The housing ministry replaced a Palantir system to match British hosts with Ukrainian refugees with its own technology. In Coventry, local politicians and unions are protesting the renewal of a £750,000 Palantir contract with the council’s children’s services department. Financial Conduct Authority employees are seeking to orchestrate a cross-union campaign against a 12-week trial contract with Palantir that they fear could expose the UK’s sensitive financial data to US law enforcement authorities. 

“Our pilot with Palantir allows the Met for the first time to bring together data it already lawfully holds in one place to identify potential standards, welfare or cultural concerns,” said a spokesperson for The Met over email. “It also allows us to identify early issues so we can act more fairly and consistently, ensuring officers receive support or face appropriate action before problems escalate.” In April, Met officers expressed outrage at the “intrusive” use of Palantir’s technology to assess them for misconduct.

The police can already request information from the NHS if it meets a policing need, such as a homicide investigation or tracing missing persons.

The Financial Conduct Authority’s contract with Palantir involves testing an AI search tool for its data. “The data used in the trial will be fully encrypted and under our control,” wrote a spokesperson for the regulator over email. “No-one is able to access the unencrypted data without our authorisation.”

Coventry City Council did not respond to questions about its Palantir contract.

What exactly does Palantir do?

Palantir’s CEO, Alex Karp, once described its role as “the finding of hidden things”. 

He co-founded the company with $2 million from the venture capital arm of the CIA in the early 2000s, when the failure to prevent 9/11 was being debated across Washington and Silicon Valley. It was suspected, and would be confirmed by the public report a year later, that the CIA, the FBI, and the National Security Agency had separately held the data required to have foreseen the terror attacks, but had “failed to connect the dots”. 

That finding has since been the basis of much of Palantir’s success. It argues that governments, militaries, law enforcement authorities and businesses already have much of the data they need to make decisions, but that it is not readily available in the forms needed. 

Palantir, it tells them, is the solution.

“The actual thing that’s difficult is organising all your data together,” Alex Bores, a member of the New York State Assembly and a former Palantir employee turned critic, told The New York Times. “That requires hard work, and there’s no magic to do that yet. The software, plus engineers going on site and doing a lot of that hard work to do the manual hookups, was always going to be the true source of value.”

Databasing the Nation

In the NHS, Palantir’s work involves organising, hooking up, and streamlining vast troves of patient data currently scattered across, by one count, 44,000 healthcare IT systems in 26,000 organisations. “The fragmentation is absolutely massive,” said Bartlett, who helped build the FDP. “There’s all this information, and it’s all sat in different pockets.” 

Palantir’s solution has two layers. Bartlett describes one layer as an “operating system” analogous to the software that runs your iPhone, which will allow NHS Trusts and third-party developers to create applications (or what Palantir calls “products”) that allow for efficiency gains. An ambulance crew, for example, could input information about an accident victim to a product that would pass it onto the hospital, so that “the A&E department could prepare, rather than being sort of hit in the face” with information when the ambulance arrives, he said.

Yet, much like how your iPhone decisively locks you into the ecosystem of Apple products, running this system efficiently requires as much of the NHS as possible to sign on to the Palantir system – something experts call “vendor lock-in” – and to draw on a staggering library of data held across the health service.

The FDP’s public documentation reveals that the platform is already in the process of ingesting several hundred databases, covering a vast array of variables that include mental healthcare contact activity, mortality, flu vaccination status, covid vaccination status, emergency services data, race and ethnicity, aggregated data for persons held in secure mental health facilities in adult prisons and immigration removal centres, and much more. 

As the cross-party committee of MPs noted in their report last week, there is little clarity around exactly what data will make it into the FDP, and how it will be accessed. The debate around patient data held by GP practices offers a useful illustration.

Back in 2023, the then secretary of state for health and social care, Victoria Atkins, told the House of Commons: “No new data will be collected, and GP data will not be part of the national platform.” However, an NHS FAQ page last updated in April 2026 admits that “some of the data” in the FDP “may have been sourced from GP records”, and GP data lawfully shared with NHS trusts that use the FDP could end up on the platform.

More worryingly, the FDP uses all this data to create detailed profiles of individual patients that it calls the ‘Person Ontology’. To quote from an NHS Data Protection Impact Assessment: “The Person Ontology serves as the single source of the truth for pseudonymised patient level datasets”. 

Elsewhere, the document says that “the Person Ontology currently holds activity data for citizens in different care settings”, explaining that the platform assigns individual patients a unique ID that can be cross-referenced across multiple databases.

The NHS says that as the data held in the FDP is pseudonymised, it does not directly identify individuals. But pseudonymisation, as has been pointed out by the Information Commissioner’s Office, the UK’s data protection watchdog, is a reversible process. “Take care not to confuse pseudonymisation with anonymisation,” the ICO warns.

A person’s healthcare data is their “most intimate information,” said a spokesperson and legal officer at Privacy International, a UK-based charity focusing on technology and rights. “We’re talking about the breadth of the data, how personal it is, and the severity of what could be done with it if it were to land in the wrong hands.”

Big Data Means Big Brother

Consolidating so much data brings very real risks of surveillance, say those familiar with the platform, particularly since Palantir also holds contracts with police forces in the UK. In principle, all that’s stopping the Home Office from accessing NHS data are legal safeguards that can be reversed.

Here in the UK, Palantir UK CEO Louis Mosley has said that if Nigel Farage’s Reform comes into power, the company will follow the party’s professed directives to use NHS data to target individuals based on their immigration status. 

Such a scenario played out in the US when Trump first became president in 2016, as Bores, the former Palantir employee, told The New York Times.

“Palantir had signed a contract with a department within ICE called HSI, Homeland Security Investigations. During the Obama administration, it was focused on anti-human trafficking, anti-drug trafficking, sometimes counterfeiting,” Bores said. “Then, when Trump comes in in 2017, they try to change the nature of that work. They try to get another part of ICE called ERO, Enforcement and Removal Operations – the part that everyone thinks of as ICE – to get access to the software and to use it for deportations.”

In the US, Palantir already uses data from the Department of Health and Human Services to track people targeted for deportation by ICE. Here in the UK, junior doctor Rhiannon Mihranian Osborne, who is organising against Palantir in the NHS with health justice organisation Medact, described what she said was a disturbing pattern: “Reform’s policy ‘Operation Restoring Justice’ wants to create a powerful immigration surveillance system by mining data from health, police and financial databases. Louis Mosley said his company would comply with this.

“Palantir’s police contracts in the UK include collating highly sensitive information on victims of crime, including sexual orientation and trade union membership. The home secretary says she wants to create a panopticon of state surveillance. The synergy between Palantir and governments who use data to abuse human rights is deeply alarming, and a sign of what could be coming in the UK.”

This is a real risk, conceded Bartlett. “Let’s take [a] Reform government and the immigration question coming in, I do worry about that scenario,” he said – but he questioned whether that means the NHS doesn’t need a Federated Data Platform. “So is the answer to that bad scenario playing out to keep the data in such a bad state that nobody could ever use it at all for good or bad?”

Palantir, NHS England, the Cabinet Office, the Department of Health and Social Care and The Reform Party did not respond to requests for comment.

Critics of the FDP, however, have pushed back against what they see as a narrative that the NHS’s systems are so hopelessly complex and tangled that the only way to solve them is with a mass surveillance tool built by Palantir.

“There’s no magic here,” Sam Smith, a technologist with patient rights organisation medConfidential, said of the FDP. “It’s not like Palantir is doing anything that other people can’t do… They’re just doing the thing because they have the mythos that they can do the thing.”

Andrew Holway, the founder of UK-based medical software startup Darwinist, told the cross-party committee that “the primary barrier to NHS innovation” is mega contracts with companies such as Palantir. These, he said, hold the NHS “hostage, preventing the implementation of modern productivity tools that could save tens of billions of pounds”.

Some in the NHS have also questioned whether the service has tried different approaches that are less intrusive and data-centric. The NHS Greater Manchester Integrated Care Board, for instance, uses its own Analytics and Data Science Platform because it believes it offers better technology and access to better data.

“Public trust isn’t a side issue for the Federated Data Platform,” wrote Matt Hennessey, the chief data and analytics officer at Manchester Integrated Care Board, in a post on LinkedIn. He outlined the “effect that ethical concern, moral unease or perceived opacity has on trust–and, in turn, on participation.”

The platform’s “main problem is that it isn’t clear what it actually is,” he wrote. “Where trust is eroded, people disengage, patients opt out, and clinicians become cautious about involvement.”

Ultimately, as Osborne said, “any NHS data system must be built on public trust, buy-in from staff, and most importantly, protection from abuse by private corporations and governments themselves”.

Article by Jade-Ruyu Yan and Aman Sethi republished from openDemocracy under a Creative Commons Attribution-NonCommercial 4.0 International licence.

We’re NHS analysts organising together against Palantir. Here’s why

By NHS Analysts Together 

The great Ministry of Defence-to-Palantir pipeline

By Ethan Shone 

Zarah Sultana: Palantir has no place in UK public services

By Zarah Sultana 

NHS Palantir data deal puts patient trust at risk, warn MP and privacy groups

By Adam Bychawski 

Continue ReadingPalantir is turning the NHS into a tool for mass surveillance

Campaigners in the UK say get Palantir out of the NHS

Spread the love

Original article by Ana Vračar republished from peoples dispatch under a Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA) license.

Source: Talia Woodin/Medact

Health workers and activists ramp up their campaign to oppose surveillance company Palantir’s role in managing NHS data

Health workers and activists in Britain are intensifying their campaign against US-based surveillance and data company Palantir, as Keir Starmer’s government accelerates its push to involve the notorious firm in managing National Health Service (NHS) data.

Palantir first gained a foothold in the NHS during the COVID-19 pandemic, securing contracts outside standard procurement processes and enjoying popularity among high-ranking health officials. The company, infamous for its involvement in operations such as the US-led invasions of Afghanistan and Iraq and migrant persecution under the US Immigration and Customs Enforcement (ICE), soon expanded its role in Britain. By last year, it had won a £330 million (USD 417 million) contract to implement the Federated Data Platform (FDP), intended to modernize medical data management across England.

Not all NHS institutions are currently able to share data because of differing systems. Both Conservative and Labour governments have identified this as the main reason for bottlenecks in the health system and claimed that resolving the problem would lead to improvements to care. However, organizations like Medact, Just Treatment, and Corporate Watch warn that entrusting this task to Palantir could deepen issues rather than solve them.

Similarly, many health experts have highlighted how the FDP would effectively lock the NHS into dependency on Palantir. The company’s systems are designed in a way to make data extraction difficult and integration with industry-standard analytics costly and complicated, so users are compelled to keep using them. “Palantir’s system pushes people to its own proprietary systems; and switching costs [for the NHS] will be very high,” Doctors’ Association and Foxglove warned in a 2023 report.

The current government is pushing forward with this form of private sector expansion in the NHS despite warnings from trusts and experts that the results will fall far short of expectations. In fact, some NHS organizations being forced to adopt the FDP under Labour’s administration have said that the new platform could result in a loss of functionality compared to the systems they currently rely on.

Read more: Labour considers expanding private sector role in NHS, undermining the already fragile public health system

While there is general agreement among analysts that data sharing and usage within the NHS could be significantly improved, they argue that these improvements can and should be achieved through local and regional initiatives. In contrast to the top-down model ushered in by the FDP, these initiatives would build on existing systems and expertise, avoiding handing over control to a private company with a track record of human rights abuses.

Concerns that the FDP could make the NHS entirely dependent on Palantir are sharpened by fears over how patient data might be used. As one of the world’s largest public healthcare systems, the NHS holds an unique health dataset. While such data has immense potential to strengthen public services, entrusting it to corporate partners poses great risks. For instance, it could be exploited for purposes such as tracking and criminalizing migrants—a practice that has been systematically pursued under Britain’s hostile environment policies.

Read more: Should health workers work with counter terrorism agencies?

Palantir takes pride in finding new applications for data, specifically to reinforce Western dominance. Given that the full scope of the FDP remains unclear, there is significant concern that NHS data could also be exploited to boost Palantir’s surveillance tools. These tools are already being deployed in Israel’s ongoing genocide against Palestinians in the Gaza Strip.

Palantir’s leadership has been outspoken in its support for Israel, openly aligning with Benjamin Netanyahu’s government even as it proceeded to kill tens of thousands of Palestinians. The company is actively testing—or rather, showcasing—its artificial intelligence (AI) models through Israel’s attacks in Palestine and Lebanon. This indicates a clear intent to monetize these tools further by marketing them to other states preparing to go on killing sprees.

Handing over NHS medical data to Palantir would deepen the Starmer administration’s complicity in Israel’s war crimes, health justice organizations warn. Such a move risks staining the NHS’s reputation, turning its dataset into a tool for oppression internationally while undermining public trust in the healthcare system at home.

Many had hoped that a change in government in July would mean an end to the FDP. However, “instead of hitting reset, Labour hit accelerate,” Just Treatment remarked during a No Palantir in the NHS meeting in November. This response reflects Labour’s priorities when it comes to the public healthcare provider. “If the government were setting out to implement reforms in the way that our data is held to improve health outcomes and improve the NHS, they would be going about it in a way that maximizes public trust, maximizes public and health service and health worker support for those initiatives,” the organization remarked during the meeting.

Instead, the government appears more interested in using national health data for economic gain. This approach aligns closely with recommendations from neoliberal policy advisors, such as those at the Tony Blair Institute for Global Change, who have recently called for the use of NHS data as a means to boost Britain’s economic standing.

Although the implementation of the FDP is progressing, activists argue that it is not too late to stop it—especially if local groups escalate their efforts. They emphasize that by increasing pressure, health workers and activists could not only push for the cancellation of Palantir’s FDP contract but also demand the termination of all agreements with companies complicit in Israel’s occupation. While Palantir is currently a key focus, the organizations highlighted that this campaign is just the beginning, serving as a starting point for broader action.

Original article by Ana Vračar republished from peoples dispatch under a Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA) license.

Continue ReadingCampaigners in the UK say get Palantir out of the NHS

Why Palantir’s latest NHS land-grab is such bad news for patients

Spread the love

Original article by Cori Crider republished from openDemocracy under a Creative Commons Attribution-NonCommercial 4.0 International licence.

OPINION: Once Palantir is inside our health service, it will be hard to get rid of. The NHS should think carefully

NHS sign

This week I debated the future of the NHS with a cardboard cutout. This was, I confess, a bit of a let-down: Louis Mosley, the UK head of Palantir, looked very fine in 2D, watermelon cocktail in hand, but we’d hoped for the man himself. He’d agreed to debate Foxglove about the NHS’s massive new plans for our health data, only to pull out at the last minute, citing ‘commitments in eastern Europe’. I suspect the real reason is that the government leant on him – and the conference organisers – to scuttle the debate. So much for public engagement.

Funny cutouts aside, this is a serious matter. The NHS, as we can see from the strikes this week, is in a historic crisis. As well as 120,000 care vacancies, the NHS has over 3,000 vacant tech roles – which stops the service from evolving to meet future needs. But instead of gripping this crisis with a credible workforce plan, the government proposes to spend nearly half a billion pounds on a database.

This is what I was hoping to debate with Louis. The government wants to give his spy-tech firm, Palantir, the contract to manage a vast new ‘Federated Data Platform’. If it goes ahead as envisaged, the FDP will be the largest single point of access to patient data this country has ever seen. It’s a pity it was left to me and Dr Marcus Baw, a GP and health IT specialist, to debate this system – because there’s so much the government won’t say about it. Like exactly what shape it will take or what purposes it will eventually serve; what it will eventually cost; who will have access; or how patient choice and consent will be honoured.

The proposed system is vast. The aim is for it to sweep in hospital, GP, even social care records – and make all this patient data available to government planners and others.

Now, parts of this are all to the good. The NHS badly needs to make better and more efficient use of patient data for the good of the NHS and of patients; there are inefficiencies in the system that urgently need fixing. But we, and many experts within the NHS we speak to, have serious concerns about the design of this contract: about whether the procurement has been fair; whether the system will work as designed; and whether Palantir, which is mainly known for supporting CIA drone attacks, predictive policing and deportation raids, is a remotely appropriate partner for the NHS.

That’s why Foxglove (with openDemocracy) brought multiple legal cases seeking to shed light on this shadowy spy-tech firm’s beachhead in the NHS since their very first £1 no-bid pandemic contract. It’s also why 50 other groups have signed the ‘No Palantir’ pledge, saying a company whose values are so manifestly opposed to those of the NHS has no place handling so much sensitive patient data.

Having one supplier to join up data and analyse it risks creating a dangerous private monopoly over vital NHS infrastructure

But there are deeper issues with the FDP. It runs the risk of stealing oxygen – and funding – from other critical work already underway to help the NHS join up its patient data for good. For example, openSafely, a flagship national data platform for health research, was developed by Ben Goldacre and a team at Oxford and was used for vital Covid research. It’s completely open source, safe and lights a way forward for trustworthy health research. It also costs a fraction of what Palantir does.

What’s more, pushing so much access and control to the centre may not make sense. For some issues – vaccination, workforce planning – there is a clear case for a national solution. But ultimately, most care is delivered locally and planned regionally. There are already places, such as London, that have pioneered solutions to pool patient data to plan care better – at a fraction of the FDP’s cost. It is far from clear how this will interact with the FDP, or whether it can survive the new system.

Other competitors – like a UK consortium of universities and open-source firms that are apparently bidding for the deal – would have loved a fair crack at the FDP contract. But let’s be honest: they probably haven’t got a snowball’s chance at beating Palantir’s incumbent advantage, won through a mixture of insider influence and watermelon cocktail lobbying.

Once Palantir’s in, it will be hard to get it out. The technical architecture is proprietary – and other government agencies have struggled to get off Palantir when they’ve tried. Having a single supplier to help you join up data and analyse it also risks creating a dangerous private monopoly over vital NHS infrastructure.

Indeed, if you take Palantir chief executive Alex Karp at his word, that’s the plan. “We are working towards a future where all large institutions in the United States and its allies abroad are running significant segments of their operations, if not their operations as a whole, on Palantir,” he wrote. “Most other companies are targeting small segments of the market. We see and intend to capture the whole.” That reads like an express statement of an intention to seek monopoly power.

It’s also clear they’re in it to profit. Their chief technology officer, Shyam Shankar, recently wrote: “The problem with defen[c]e contracting is not the popular narrative that contractors make too much money. It is actually that they make too little money… Innovators will need outsized profits to motivate progress.” Monopoly and profiteering may be good for Palantir’s share price, but they sit uncomfortably with the ethos of a public health service.

Joining up the NHS’s disparate health data systems better will present stiff challenges, and the NHS will face trade-offs – buying in consultants may be easier in the short term, for example, but may prove more expensive in the long run. But at the moment the government is stonewalling legal letters asking even basic questions about the FDP. And they are also creating facts on the ground that could be seen to favour Palantir. The legal basis for all of this, now that the pandemic’s suspension of protections for patient data has lapsed, is unclear.

People care deeply about how their health data is used. We go to the doctor to share our worries, our fears, and our pain – and if we don’t trust that conversation to be private, we may not go at all. People want to feel safe to contribute their health data for the good of the NHS – but when the government runs out ahead of patient trust, overhauling patient data systems without explaining what it wants to do, who will see the data, and what safeguards there are, people baulk. In 2021 more than a million people in a month opted out of sharing their health data because they didn’t trust the government’s last plans to pool their GP records. The history of the NHS is a boneyard of such schemes: massive, expensive white elephants that all failed because the government didn’t take the time to get the governance or consent right.

It is past time for the government to learn from these mistakes. We can build a better future for our patient data – if we take the time to design carefully, honouring patient choice and thinking about what system will serve the NHS for the long haul. Anything less is likely to fail and set the cause of progress back another five years.

Original article by Cori Crider republished from openDemocracy under a Creative Commons Attribution-NonCommercial 4.0 International licence.

Continue ReadingWhy Palantir’s latest NHS land-grab is such bad news for patients